Background And Study Aims: Mannan-binding lectin (MBL) is a collectin synthesised in the liver and secreted into the bloodstream. It binds micro-organisms via interactions with glycans on the target surface. Bound MBL subsequently activates MBL-associated serine protease proenzymes (MASPs). Several studies have investigated the possible role for MBL in hepatitis C virus (HCV) infection by examining MBL levels and polymorphisms in relation to disease progression and in response to treatment. The aim of this study was to investigate the relation of the activity of MBL and MBL/MASP-1 complex in sera of patients with mild and severe chronic HCV infection and outcome of HCV infection.
Patients And Methods: Serum level of MBL and functional assays for MBL/MASP-1 complex activity were assayed in sera of 80 patients with chronic HCV infection. Patients were divided into two groups according to the results of the liver biopsy, group I (40 HCV patients had mild hepatic fibrosis, Ishak fibrosis stages 0-1) and group II (40 HCV patients had severe hepatic fibrosis, Ishak fibrosis stages 5-6), in addition to 20 control subjects as group III. The analysis of the MBL/MASP-1 complex activity at 0, 3 and 6 months was performed in all patients.
Results: Serum levels of MBL and MBL/MASP-1 complex activity were higher in sera of patients with chronic HCV liver disease compared to those in control subjects. There was a correlation between the activity of the MBL/MASP-1 complex and the severity of fibrosis (P=0.003). MBL/MASP-1 complex activity was associated more significantly with severe fibrosis in comparison to MBL concentration.
Conclusion: MBL and MBL/MASP-1 complex activities play a key role in first-line host defence mechanism against certain infectious agents including HCV infection. However, it is also likely that the role of MBL and MBL/MASP-1 complex activity extends beyond this restricted infection-related view in that it appears to be a key regulator of inflammation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ajg.2011.04.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT).
Front Immunol
October 2019
Laboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Łódź, Poland.
Article Synopsis
- - This study involved 312 patients with multiple myeloma and lymphomas undergoing high-dose chemotherapy and autologous stem cell transplantation, examining the role of certain gene polymorphisms and serum concentrations of immune-related proteins.
- - Findings indicated that multiple myeloma patients had a higher prevalence of MBL deficiency genotypes, but this was not linked to hospital infections or recovery of white blood cells, although it correlated with more severe infections during follow-up.
- - Interestingly, high levels of MBL were associated with prolonged fever and some infections post-chemotherapy, while a notable association between a gene mutation and lymphoma was identified, and overall, the influence of MBL on infections in these patients remains conflicting.
Distinct Longitudinal Associations of MBL, MASP-1, MASP-2, MASP-3, and MAp44 With Endothelial Dysfunction and Intima-Media Thickness: The Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) Study.
Arterioscler Thromb Vasc Biol
June 2016
From the Department of Internal Medicine (E.H., C.J.H.v.d.K., C.G.S., C.D.A.S., M.M.J.v.G.), CARIM School for Cardiovascular Diseases (EH, C.J.H.v.d.K., C.G.S., C.D.A.S., M.M.J.v.G., I.C.W.A.), Department of Epidemiology, School for Public Health and Primary Care (CAPHRI) (I.C.W.A.), Maastricht University Medical Centre, Maastricht, The Netherlands; Division of Human Nutrition, Section Nutrition and Epidemiology, Wageningen University, Wageningen, The Netherlands (E.J.M.F.); and Department of Biomedicine, Aarhus University, Aarhus, Denmark (I.T.H.-P., S.T.).
Objective: Previous studies suggested that the lectin-complement pathway plays a complex role in cardiovascular disease (CVD). To date, no prospective human studies have investigated the relationship between the initiating factor of the lectin pathway, that is, mannose-binding lectin (MBL), and low-grade inflammation, endothelial dysfunction, or carotid intima-media thickness (cIMT). Moreover, MBL-associated proteases (MASPs) and MBL-associated proteins (MAps), which mediate downstream complement activation, have not been studied in the development of CVD.
View Article and Find Full Text PDFStructural insights into the initiating complex of the lectin pathway of complement activation.
Structure
February 2015
Department of Biomedicine, Aarhus University, Bartholins Allé 6 and Wilhelm Meyers Allé 3, 8000 Aarhus, Denmark. Electronic address:
Article Synopsis
- The complement system's proteolytic cascade starts when pattern-recognition molecules (PRMs) attach to specific ligands, triggering the activation of associated proteases.
- In the lectin pathway, the mannan-binding lectin (MBL) combined with MBL-associated serine protease-1 (MASP-1) activates another protease, MASP-2.
- A structural study revealed that the MASP-1 dimer's serine protease domains extend from the MBL tetramer, suggesting an intercomplex activation mechanism rather than the previously assumed intracomplex initiation.
Fibrosis severity and mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex in HCV-infected patients.
Arab J Gastroenterol
June 2011
Departments of Tropical Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.
Background And Study Aims: Mannan-binding lectin (MBL) is a collectin synthesised in the liver and secreted into the bloodstream. It binds micro-organisms via interactions with glycans on the target surface. Bound MBL subsequently activates MBL-associated serine protease proenzymes (MASPs).
View Article and Find Full Text PDFCrystal structure of the CUB1-EGF-CUB2 domain of human MASP-1/3 and identification of its interaction sites with mannan-binding lectin and ficolins.
J Biol Chem
September 2008
Laboratoire d'Enzymologie Moléculaire, 38027 Grenoble Cedex 1, France. Electronic address:
MASP-1 and MASP-3 are homologous proteases arising from alternative splicing of the MASP1/3 gene. They include an identical CUB(1)-EGF-CUB(2)-CCP(1)-CCP(2) module array prolonged by different serine protease domains at the C-terminal end. The x-ray structure of the CUB(1)-EGF-CUB(2) domain of human MASP-1/3, responsible for interaction of MASP-1 and -3 with their partner proteins mannan-binding lectin (MBL) and ficolins, was solved to a resolution of 2.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!